HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carmine Giorgio Selected Research

cholanic acid

10/2013Synthesis and structure-activity relationships of amino acid conjugates of cholanic acid as antagonists of the EphA2 receptor.
6/2012Structure-activity relationships and mechanism of action of Eph-ephrin antagonists: interaction of cholanic acid with the EphA2 receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carmine Giorgio Research Topics

Disease

18Neoplasms (Cancer)
04/2020 - 03/2011
7Carcinogenesis
05/2021 - 03/2011
4Prostatic Neoplasms (Prostate Cancer)
11/2015 - 06/2012
3Colitis
05/2021 - 01/2019
3Inflammation (Inflammations)
05/2021 - 01/2019
3Glioblastoma (Glioblastoma Multiforme)
02/2020 - 12/2017
2Crohn Disease (Crohn's Disease)
05/2021 - 05/2021
2Adenocarcinoma
09/2012 - 11/2011
1Mesenteric Ischemia
05/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2021
1Colorectal Neoplasms (Colorectal Cancer)
04/2020
1Adenoma (Adenomas)
04/2020
1Intestinal Neoplasms (Intestinal Cancer)
04/2020
1Cystic Fibrosis (Mucoviscidosis)
12/2019
1Phototoxic Dermatitis (Phototoxicity)
09/2019
1Hepatocellular Carcinoma (Hepatoma)
01/2019
1Brain Neoplasms (Brain Tumor)
05/2018
1Hematologic Neoplasms (Hematological Malignancy)
12/2017
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2017
1Lung Neoplasms (Lung Cancer)
12/2017
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2014
1Pathologic Processes
05/2014
1Carcinoma (Carcinomatosis)
01/2014
1Colonic Neoplasms (Colon Cancer)
03/2011
1Edema (Dropsy)
06/2010
1Peritonitis
05/2009

Drug/Important Bio-Agent (IBA)

15EphrinsIBA
05/2021 - 03/2011
6LigandsIBA
04/2020 - 11/2011
4Proteins (Proteins, Gene)FDA Link
05/2021 - 05/2014
4AcidsIBA
05/2021 - 04/2013
3Eph Family Receptors (Eph Receptors)IBA
04/2020 - 01/2019
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
09/2012 - 03/2011
2Recombinant ProteinsIBA
05/2021 - 12/2017
2Tyrosine (L-Tyrosine)FDA Link
04/2020 - 01/2019
2Phosphotransferases (Kinase)IBA
04/2020 - 01/2019
2EphA2 ReceptorIBA
03/2020 - 06/2012
2Pharmaceutical PreparationsIBA
02/2020 - 09/2019
2Lithocholic AcidIBA
01/2016 - 04/2013
2cholanic acidIBA
10/2013 - 06/2012
1Proteinase-Activated ReceptorsIBA
05/2021
1ThrombinFDA Link
05/2021
1DabigatranFDA Link
05/2021
1Peptide Hydrolases (Proteases)FDA Link
05/2021
1UniPR129IBA
04/2020
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
12/2019
1Serum AlbuminIBA
09/2019
1CurcuminIBA
09/2019
1Bovine Serum AlbuminIBA
09/2019
1apomyoglobinIBA
01/2019
1SodiumIBA
01/2019
1Dextrans (Dextran)FDA Link
01/2019
1Photosensitizing Agents (Photosensitizers)IBA
01/2019
1ErythropoietinFDA Link
01/2019
1hypericinIBA
01/2019
1Ephrin-B2 (Ephrin B2)IBA
01/2019
1EphA1 Receptor (Eph Receptor)IBA
05/2018
1Peptides (Polypeptides)IBA
12/2017
1Biological ProductsIBA
12/2017
1AntibodiesIBA
12/2017
1Tryptophan (L-Tryptophan)FDA Link
01/2016
1SteroidsIBA
01/2016
1ellagitanninIBA
11/2015
1urolithin DIBA
11/2015
1Carboxylic AcidsIBA
01/2014
1GW 4064IBA
01/2014
1StilbenesIBA
01/2014
1protocatechuic acidIBA
09/2012
1PyrogallolIBA
09/2012
1Phenol (Carbolic Acid)FDA Link
09/2012
1Epidermal Growth Factor (EGF)IBA
11/2011
1Volatile Oils (Essential Oils)IBA
06/2010
1CarrageenanIBA
06/2010
1cinnamaldehyde (cinnamic aldehyde)FDA Link
06/2010
1ZymosanIBA
05/2009

Therapy/Procedure

4Therapeutics
01/2020 - 12/2017
2Photochemotherapy (Photodynamic Therapy)
09/2019 - 01/2019
1Radiotherapy
05/2018
1Drug Therapy (Chemotherapy)
05/2018